Marino Labinaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marino Labinaz has a total of 185 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin Hibbert
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA
6 shared publications Michael Froeschl
5 shared publicationsMichel Le May
5 shared publicationsAlexander Dick
University of Ottawa Heart Institute, Ottawa, Ontario, Canada
4 shared publicationsAun-Yeong Chong
4 shared publicationsChris Glover
4 shared publications
Latest Publications
- Open Access
- 26 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (7) , 2257
Concomitant Transcatheter Edge-to-Edge Repair and Left Atrial Appendage Occlusion
Background/Objectives: Atrial fibrillation is a frequent comorbidity amongst patients undergoing mitral valve transcatheter edge-to-edge repair (M-TEER) for mitral regurgitation. Left atrial appendage occlusion (LAAO) can be performed to reduce the risk of stroke in patients with atrial fibrillation. Both procedures require large-bore venous access, transseptal puncture, and real-time imaging of the left atrium. However, limited data exist evaluating the safety and feasibility of concomitant M-TEER and LAAO. Methods: We performed a retrospective review of all concomitant M-TEER and LAAO procedures at our institution between May 2019 and September 2024 to evaluate the safety and feasibility of this approach. Results: Concomitant left atrial appendage occlusion was successful in all 15 patients, requiring an additional 15 min (IQR 11–29) of procedural time. No patients died or had a major vascular complication. Routine transesophageal echocardiography performed within 90 days showed no device related thrombus, and no significant peri-device leak in any patients. Conclusions: Concomitant M-TEER and LAAO are feasible but additional prospective studies or randomized trials are needed to evaluate the potential clinical benefit.
- 26 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (7) , 2257
Open AccessConcomitant Transcatheter Edge-to-Edge Repair and Left Atrial Appendage Occlusion
Background/Objectives: Atrial fibrillation is a frequent comorbidity amongst patients undergoing mitral valve transcatheter edge-to-edge repair (M-TEER) for mitral regurgitation. Left atrial appendage occlusion (LAAO) can be performed to reduce the risk of stroke in patients with atrial fibrillation. Both procedures require large-bore venous access, transseptal puncture, and real-time imaging of the left atrium. However, limited data exist evaluating the safety and feasibility of concomitant M-TEER and LAAO. Methods: We performed a retrospective review of all concomitant M-TEER and LAAO procedures at our institution between May 2019 and September 2024 to evaluate the safety and feasibility of this approach. Results: Concomitant left atrial appendage occlusion was successful in all 15 patients, requiring an additional 15 min (IQR 11–29) of procedural time. No patients died or had a major vascular complication. Routine transesophageal echocardiography performed within 90 days showed no device related thrombus, and no significant peri-device leak in any patients. Conclusions: Concomitant M-TEER and LAAO are feasible but additional prospective studies or randomized trials are needed to evaluate the potential clinical benefit.
- 1 March 2017
- Vol. 26 (2) , 139-145
Efficacy and Complications of Transcatheter Aortic Valve Implantation With and Without Balloon Aortic Valvuloplasty.
Transcatheter aortic valve implantation (TAVI) is an effective treatment for severe aortic stenosis in high-risk patients. Several complications related to the TAVI procedure, including aortic regurgitation (AR), cerebrovascular accident (CVA) and the requirement for permanent pacemaker (PPM), are thought to be secondary to balloon aortic valvuloplasty (BAV) before TAVI. The aim of the present review was to evaluate any beneficial role of the direct TAVI approach over BAVTAVI. A comprehensive search of major databases was performed. Only studies comparing TAVI with and without BAV were included. A total of nine full length articles was included in the analysis. Among 2,650 patients, 1,043 underwent 'direct TAVI' without pre-BAV, while 1,607 underwent TAVI following BAV. Overall, there was no difference between the 30-day all-cause mortality (OR 0.96, 95% CI 0.63-1.47, p = 0.86), CVA (OR 0.81, 95% CI 0.34-1.92, p = 0.63) and PPM implantation (OR 0.84, 95% CI 0.66- 1.05, p = 0.12) between the two approaches. The rate of moderate to severe AR was significantly lower with direct TAVI implantation (OR 0.44, 95% CI 0.20-0.96, p = 0.04). In the case of self-expandable valves, direct TAVI was associated with a lower device success (OR 5.15, 95% CI 1.33-19.9, p = 0.02). No difference was identified in mortality between direct TAVI and BAV-TAVI. However, direct TAVI is associated with a lower incidence of AR, a finding that would only be confirmed by conducting further randomized studies.
- 1 March 2017
- Vol. 26 (2) , 139-145
Efficacy and Complications of Transcatheter Aortic Valve Implantation With and Without Balloon Aortic Valvuloplasty.
Transcatheter aortic valve implantation (TAVI) is an effective treatment for severe aortic stenosis in high-risk patients. Several complications related to the TAVI procedure, including aortic regurgitation (AR), cerebrovascular accident (CVA) and the requirement for permanent pacemaker (PPM), are thought to be secondary to balloon aortic valvuloplasty (BAV) before TAVI. The aim of the present review was to evaluate any beneficial role of the direct TAVI approach over BAVTAVI. A comprehensive search of major databases was performed. Only studies comparing TAVI with and without BAV were included. A total of nine full length articles was included in the analysis. Among 2,650 patients, 1,043 underwent 'direct TAVI' without pre-BAV, while 1,607 underwent TAVI following BAV. Overall, there was no difference between the 30-day all-cause mortality (OR 0.96, 95% CI 0.63-1.47, p = 0.86), CVA (OR 0.81, 95% CI 0.34-1.92, p = 0.63) and PPM implantation (OR 0.84, 95% CI 0.66- 1.05, p = 0.12) between the two approaches. The rate of moderate to severe AR was significantly lower with direct TAVI implantation (OR 0.44, 95% CI 0.20-0.96, p = 0.04). In the case of self-expandable valves, direct TAVI was associated with a lower device success (OR 5.15, 95% CI 1.33-19.9, p = 0.02). No difference was identified in mortality between direct TAVI and BAV-TAVI. However, direct TAVI is associated with a lower incidence of AR, a finding that would only be confirmed by conducting further randomized studies.
- 13 June 2015
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 32 (2) , 266-269
Transcatheter Aortic Valve Implantation: Current and Evolving Indications
- 13 June 2015
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 32 (2) , 266-269
Transcatheter Aortic Valve Implantation: Current and Evolving Indications
- 1 June 2015
- Published by Elsevier in International Journal of Cardiology
- Vol. 189, 282-288
Transcatheter aortic valve implantation in patients with bicuspid aortic valve: A patient level multi-center analysis
- 1 June 2015
- Published by Elsevier in International Journal of Cardiology
- Vol. 189, 282-288
Transcatheter aortic valve implantation in patients with bicuspid aortic valve: A patient level multi-center analysis
- 24 December 2014
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 31 (4) , 548.e5-548.e7
Pulmonary Hypertension due to Fibrosing Mediastinitis Treated Successfully With Stenting of Pulmonary Vein Stenoses
- 24 December 2014
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 31 (4) , 548.e5-548.e7
Pulmonary Hypertension due to Fibrosing Mediastinitis Treated Successfully With Stenting of Pulmonary Vein Stenoses
- 1 September 2014
- Published by Elsevier in International Journal of Cardiology
- Vol. 176 (2) , 562-564
Performance of transcatheter aortic valve implantation in patients with bicuspid aortic valve: Systematic review
- 1 September 2014
- Published by Elsevier in International Journal of Cardiology
- Vol. 176 (2) , 562-564
Performance of transcatheter aortic valve implantation in patients with bicuspid aortic valve: Systematic review